Cardiometabolic drugs

Cardiometabolic drugs

We at Farma care for the health or your heart with medications for cardiovascular and metabolic disorders, such as arterial hypertension, diabetes and high blood cholesterol.

Medications for
cardiometabolic diseases

Actumir

Actumir® active ingredient:

10 mg empagliflozin.

Actumir® indications:

  • All stages of arterial hypertension.
  • Diabetes mellitus associated with arterial hypertension.
  • Kidney failure with or without proteinuria.

Actumir® presentations:

  • 10 mg coated tablets x 10
  • 10 mg coated tablets x 30
Aranda

Active ingredient in Aranda®:

amlodipine besylate – losartan potassium

Aranda® indications:

  • All stages of arterial hypertension.
  • Diabetes mellitus associated with arterial hypertension.
  • Kidney failure with or without proteinuria.

Dosage forms of Aranda®:

  • 2.5 mg/50 mg capsules x 30
  • 5 mg/100 mg capsules x 30
Arudil

Active component of Arudil®:

rivaroxaban

Arudil® indications:

  • Prevention of cerebrovascular accidents (CVA) and systemic embolism in patients with non-valvular atrial fibrillation (NVAF).
  • Treatment and prevention of deep vein thrombosis (DVT).
  • Treatment and prevention of pulmonary embolism (PE).

Dosage forms of Arudil®:

  • 10 mg coated tablets x 10
  • 10 mg coated tablets x 30
  • 15 mg coated tablets x 10
  • 15 mg coated tablets x 30
  • 20 mg coated tablets x 10
  • 20 mg coated tablets x 30
Brasartan

Active ingredient in Brasartan®:

valsartan

Brasartan® indications:

  • Arterial hypertension.
  • Heart failure.

Dosage forms of Brasartan®:

  • 80 mg capsules x 10
  • 80 mg capsules x 30
Brasartan

Active component of Brasartan® CTDN:

valsartan – chlorthalidone

Brasartan® CTDN indications:

  • Second-line treatment for patients who  do not respond to monotherapy.

Dosage forms of Brasartan® CTDN:

  • 80 mg / 12.5 mg coated tablets x 10
  • 80 mg / 12.5 mg coated tablets x 30
  • 160 mg / 12,5 mg coated tablets x 30
Corazem

Active ingredient in Corazem®:

diltiazem

Corazem® indications:

  • Mild to moderate arterial hypertension.
  • Unstable angina.
  • Stable angina.
  • Angina associated with coronary artery spasm.

Dosage forms of Corazem®:

  • 60 mg coated tablets x 20
Crisomet

Active ingredient of Crisomet® :

sitagliptin – metformin

Crisomet® indications:

  • Treatment of  type 2 diabetes mellitus and adjuvant to diet and exercise in patients in whom monotherapy is not effective.

Dosage forms of Crisomet®:

  • 50 mg/ 500 mg coated tablets x 10
  • 50 mg/ 500 mg coated tablets x 30
  • 50 mg/ 500 mg coated tablets x 60
  • 50 mg/ 850 mg coated tablets x 10
  • 50 mg/ 850 mg coated tablets x 30
  • 50 mg/ 850 mg coated tablets x 60

¿Qué es Crisomet?

En Venezuela Crisomet® de Laboratorios Farma es Sitagliptina – Metformina, apropiado para el control de los niveles de glucosa (azúcar) en sangre e indicado para el tratamiento de la diabetes tipo 2.

¿Qué es Sitagliptina – Metformina clorhidrato?

Sitagliptina – Metformina es una combinación de dos medicamentos utilizados en el control de los niveles de glucosa (azúcar) en sangre, están indicados para el tratamiento de la diabetes tipo 2.

¿Para qué sirve la Sitagliptina – Metformina?

Sirve para reducir los niveles de glucosa en sangre de los diabéticos tipo 2. Disminuye de manera efectiva los valores de hemoglobina glicosilada, que es el parámetro que se ha fijado como meta a alcanzar en el diabético y poder decir que está en control glucémico.

¿Cómo actúa la Sitagliptina – Metformina?

Metformina, mejora la sensibilidad de la hormona insulina sobre los tejidos que utilizan la glucosa, eso hace que estos tejidos puedan aprovecharla y se encuentre baja en sangre. Sitagliptina, aumenta el tiempo de vida de unas hormonas llamadas incretinas, las cuales mejoran el funcionamiento del páncreas para la producción de insulina. Adicional a otros efectos que también contribuyen al control de la glucosa. Sitagliptina – Metformina, al actuar por mecanismos diferentes sus efectos se vuelven complementarios y potencian la efectividad que posee cada uno por su parte.

¿Crisomet es un antiepiléptico?

En otros países existe un medicamento con el nombre Crisomet, el cual posee como principio activo Lamotrigina, que es un antiepiléptico. En Venezuela, Crisomet de Laboratorios Farma es Sitagliptina – Metformina.

Laboratorios Farma wishes to inform the medical and pharmaceutical community that its product Crisomet® is now available at drugstores and pharmacies.

Sitagliptin 50 mg / metformin hydrochloride 500 mg, coated tablets x 10, 30 and 60 E.F.41.808/17 Sitagliptin 50 mg / metformin hydrochloride 850 mg, coated tablets x 10, 30 and 60 E.F.41.809/17

For further information, contact: Laboratorios Farma S.A., Av. Principal de los Ruices., Edif FARMA, Caracas-Venezuela 1071. Telf.: +58 212 202-6200 / E-mail: [email protected] Rif: J-00013393-0. Medications should only be purchased at pharmacies and establishments duly authorized by the People’s Power Ministry for Health .
Flebosmin

Active ingredient in Flebosmin®:

diosmin – hesperidin 

Flebosmin® indications:

  •  Chronic venous insufficiency, varicose veins and hemorrhoids.

Dosage form of Flebosmin®:

  • 500 mg coated tablets x 30
Hidroten

Active ingredient in Hidroten®:

chlorthalidone

Hidroten® indications:

  • Treatment of arterial hypertension and isolated systolic hypertension.

Dosage form of  Hidroten®:

  • 12.5 mg tablets x 30
Lipacomb

Active ingredient in Lipacomb®:

simvastatin – ezetimibe

Lipacomb® indications:

  • Treatment of primary hypercholesterolemia.
  • Homozygous familial hypercholesterolemia.

Dosage form of Lipacomb®:

  • 20 mg/ 10 mg tablets x 30
Aranda

Neblum® active ingredient:

Sacubitril 24.3 mg/ valsartan 25.7 mg

Neblum® indications:

  • Treatment of heart failure (NYHA class II-IV) in patients with systolic dysfunction.

Neblum® presentations:

  • 24.3mg / 25.7mg film-coated tablets x 30
Nifelan

Principio activo de Nifelan® CD:

nifedipine

Nifelan® CD indications:

  • Treatment of  mild, moderate and severe arterial hypertension. Treatment of  chronic stable angina (exertion angina), including Prinzmetal or variant angina.

Dosage form of Nifelan® CD:

  • 30 mg coated tablets x 30
Regulip

Active ingredient in Regulip®:

rosuvastatin

Regulip® indications:

  • Treatment of patients with primary or secondary hypercholesterolemia, combined  hyperlipidemia, and homozygous  and heterozygous familial  hypercholesterolemia,   when response to diet and other measures has proven  inadequate.

Dosage forms of Regulip®:

  • 10 mg coated tablets x 10
  • 10 mg coated tablets x 30
Tornevol

Active ingredient in Tonervol®:

nebivolol

Tonervol® indications:

  • Essential arterial hypertension.
  • Stable chronic heart failure.

Dosage forms of Tonervol®:

  • 5 mg tablets x 10
  • 5 mg tablets x 30
  • 5 mg tablets x 50